Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasm Metastasis 32Multiple Myeloma 23Leukemia, Myeloid, Acute 23Lymphoma 17Colorectal Neoplasms 16Breast Neoplasms 14Pancreatic Neoplasms 12Myelodysplastic Syndromes 12Triple Negative Breast Neoplasms 10Sarcoma 9Prostatic Neoplasms 9Leukemia, Lymphocytic, Chronic, B-Cell 9Burkitt Lymphoma 9Ovarian Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, T-Cell 7Glioma 7Endometrial Neoplasms 7Neuroblastoma 6Melanoma 6Lymphoma, Non-Hodgkin 6Lung Neoplasms 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Myeloproliferative Disorders 5Lymphoma, Follicular 5Fallopian Tube Neoplasms 5Cholangiocarcinoma 5Central Nervous System Neoplasms 5

Interventions

dinutuximab 2Vincristine 2Topotecan 2Thiotepa 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Isotretinoin 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2sargramostim 1Transurethral Resection of Bladder 1Temozolomide 1Specimen Handling 1Razoxane 1Radiotherapy 1Proton Therapy 1Nuclear Medicine Department, Hospital 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Irinotecan 1Hematopoietic Stem Cell Transplantation 1Dexrazoxane 1Congresses as Topic 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Biopsy × 30 days × Clear all
NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡